Drug Resistance Updates

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drug Resistance Updates is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,930 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1532-2084 · 1368-7646
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,930 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,930 USD
Declared review time (DOAJ)
—
Actual review time (measured)
96 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1231

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

160

i10-index

786

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
48%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9815369
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
Show all subjects (50)
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Cell death mechanisms and regulation
  • Cell death mechanisms and regulation
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • RNA Interference and Gene Delivery
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • RNA Interference and Gene Delivery
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Antifungal resistance and susceptibility
  • Epigenetics and DNA Methylation
  • Antifungal resistance and susceptibility
  • RNA modifications and cancer
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • HER2/EGFR in Cancer Research
  • Ubiquitin and proteasome pathways
  • Nanoplatforms for cancer theranostics
  • Protein Degradation and Inhibitors
  • HER2/EGFR in Cancer Research
  • Nanoplatforms for cancer theranostics
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • Bacterial Genetics and Biotechnology
  • Bacterial Genetics and Biotechnology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: